Telemedicine and remote management of patients with heart failure

Stefan D. Anker, Friedrich Koehler, William T. Abraham

Research output: Contribution to journalArticle

184 Citations (Scopus)

Abstract

Advances in telecommunication technologies have created new opportunities to provide telemedical care as an adjunct to medical management of patients with heart failure. Meta-analyses suggest that telemedicine can reduce morbidity and mortality in such patients; however, two prospective clinical trials not included in the analyses do not support these findings. Therefore, the effectiveness of telemedicine in heart failure is not established. Telemedicine approaches range from computer-based support systems to programmes led by nurses and physicians. Standardisation and appropriate classification of telemedical systems are needed to enable accurate interpretation of clinical trials. Here we propose a classification of four generations of telemedicine in heart failure. Not all approaches are the same and not every patient with heart failure will need telemedicine. Crisis prevention and treatment, and stabilisation and self-empowerment of patients are focuses of telemedicine in heart failure. The profile of patients who can potentially benefit from telemedicine is unknown and should be investigated in adequately powered randomised clinical trials. We are optimistic that telemedicine is an efficient approach and will become an important feature of management in heart failure.

Original languageEnglish
Pages (from-to)731-739
Number of pages9
JournalLancet
Volume378
Issue number9792
DOIs
Publication statusPublished - 2011

Fingerprint

Telemedicine
Heart Failure
Clinical Trials
Telecommunications
Patient Participation
Meta-Analysis
Randomized Controlled Trials
Nurses
Technology
Morbidity
Physicians
Mortality

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Telemedicine and remote management of patients with heart failure. / Anker, Stefan D.; Koehler, Friedrich; Abraham, William T.

In: Lancet, Vol. 378, No. 9792, 2011, p. 731-739.

Research output: Contribution to journalArticle

Anker, SD, Koehler, F & Abraham, WT 2011, 'Telemedicine and remote management of patients with heart failure', Lancet, vol. 378, no. 9792, pp. 731-739. https://doi.org/10.1016/S0140-6736(11)61229-4
Anker, Stefan D. ; Koehler, Friedrich ; Abraham, William T. / Telemedicine and remote management of patients with heart failure. In: Lancet. 2011 ; Vol. 378, No. 9792. pp. 731-739.
@article{0c8c7b573f8c4a2dadbcf19d48f81cd5,
title = "Telemedicine and remote management of patients with heart failure",
abstract = "Advances in telecommunication technologies have created new opportunities to provide telemedical care as an adjunct to medical management of patients with heart failure. Meta-analyses suggest that telemedicine can reduce morbidity and mortality in such patients; however, two prospective clinical trials not included in the analyses do not support these findings. Therefore, the effectiveness of telemedicine in heart failure is not established. Telemedicine approaches range from computer-based support systems to programmes led by nurses and physicians. Standardisation and appropriate classification of telemedical systems are needed to enable accurate interpretation of clinical trials. Here we propose a classification of four generations of telemedicine in heart failure. Not all approaches are the same and not every patient with heart failure will need telemedicine. Crisis prevention and treatment, and stabilisation and self-empowerment of patients are focuses of telemedicine in heart failure. The profile of patients who can potentially benefit from telemedicine is unknown and should be investigated in adequately powered randomised clinical trials. We are optimistic that telemedicine is an efficient approach and will become an important feature of management in heart failure.",
author = "Anker, {Stefan D.} and Friedrich Koehler and Abraham, {William T.}",
year = "2011",
doi = "10.1016/S0140-6736(11)61229-4",
language = "English",
volume = "378",
pages = "731--739",
journal = "The Lancet",
issn = "0140-6736",
publisher = "Lancet Publishing Group",
number = "9792",

}

TY - JOUR

T1 - Telemedicine and remote management of patients with heart failure

AU - Anker, Stefan D.

AU - Koehler, Friedrich

AU - Abraham, William T.

PY - 2011

Y1 - 2011

N2 - Advances in telecommunication technologies have created new opportunities to provide telemedical care as an adjunct to medical management of patients with heart failure. Meta-analyses suggest that telemedicine can reduce morbidity and mortality in such patients; however, two prospective clinical trials not included in the analyses do not support these findings. Therefore, the effectiveness of telemedicine in heart failure is not established. Telemedicine approaches range from computer-based support systems to programmes led by nurses and physicians. Standardisation and appropriate classification of telemedical systems are needed to enable accurate interpretation of clinical trials. Here we propose a classification of four generations of telemedicine in heart failure. Not all approaches are the same and not every patient with heart failure will need telemedicine. Crisis prevention and treatment, and stabilisation and self-empowerment of patients are focuses of telemedicine in heart failure. The profile of patients who can potentially benefit from telemedicine is unknown and should be investigated in adequately powered randomised clinical trials. We are optimistic that telemedicine is an efficient approach and will become an important feature of management in heart failure.

AB - Advances in telecommunication technologies have created new opportunities to provide telemedical care as an adjunct to medical management of patients with heart failure. Meta-analyses suggest that telemedicine can reduce morbidity and mortality in such patients; however, two prospective clinical trials not included in the analyses do not support these findings. Therefore, the effectiveness of telemedicine in heart failure is not established. Telemedicine approaches range from computer-based support systems to programmes led by nurses and physicians. Standardisation and appropriate classification of telemedical systems are needed to enable accurate interpretation of clinical trials. Here we propose a classification of four generations of telemedicine in heart failure. Not all approaches are the same and not every patient with heart failure will need telemedicine. Crisis prevention and treatment, and stabilisation and self-empowerment of patients are focuses of telemedicine in heart failure. The profile of patients who can potentially benefit from telemedicine is unknown and should be investigated in adequately powered randomised clinical trials. We are optimistic that telemedicine is an efficient approach and will become an important feature of management in heart failure.

UR - http://www.scopus.com/inward/record.url?scp=80051994560&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80051994560&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(11)61229-4

DO - 10.1016/S0140-6736(11)61229-4

M3 - Article

VL - 378

SP - 731

EP - 739

JO - The Lancet

JF - The Lancet

SN - 0140-6736

IS - 9792

ER -